• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受排卵诱导的中国多囊卵巢综合征女性中,基线促黄体生成素/促卵泡生成素比值升高与排卵反应不良相关,但临床妊娠和活产情况较好。

Elevated baseline LH/FSH ratio is associated with poor ovulatory response but better clinical pregnancy and live birth in Chinese women with PCOS after ovulation induction.

作者信息

Xia Qing, Xie Liangzhen, Wu Qi, Cong Jing, Ma Hongli, Li Jian, Cai Wangyu, Wu Xiaoke

机构信息

Department of Obstetrics and Gynaecology, Heilongjiang University of Chinese Medicine, Harbin 150001, China.

Department of Obstetrics and Gynaecology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100010, China.

出版信息

Heliyon. 2023 Jan 18;9(1):e13024. doi: 10.1016/j.heliyon.2023.e13024. eCollection 2023 Jan.

DOI:10.1016/j.heliyon.2023.e13024
PMID:36711322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9876966/
Abstract

BACKGROUND

What is the association between elevated baseline LH/FSH ratio and reproductive outcomes, especially ovulatory response, among Chinese women with polycystic ovary syndrome (PCOS) after ovulation induction.

METHODS

This was a secondary analysis of a multicenter randomized trial in 1000 women with PCOS from 21 sites (27 hospitals) in Mainland China. LH and FSH levels before ovulation induction and the main outcomes including ovulation, biochemical pregnancy, clinical pregnancy, miscarriage, and live birth were measured. A linear regression model, logistic regression models and Cox proportional hazard regression model were used to estimate the association between LH/FSH ratios and reproductive outcomes in PCOS.

RESULTS

LH/FSH ratio was significantly associated with age, body mass index (BMI), total testosterone (TT), estradiol (E2), free testosterone (FT), and antimullerian hormone (AMH). Anovulatory women had significantly higher LH/FSH ratio than ovulatory women (P = 0.003), especially in women with young age (P = 0.023), high BMI (P = 0.002), low E2 (P = 0.002), FT (P = 0.010), TT (P < 0.001) and AMH(P = 0.032). Women with elevated LH/FSH ratio were associated with lower ovulation (LH/FSH≥1 OR = 0.42, 95% CI, 0.26-0.68; LH/FSH≥2 OR = 0.32, 95% CI, 0.20-0.54; LH/FSH≥3 OR = 0.40, 95% CI 0.21-0.74) when compared with LH/FSH<1. The association was held after adjustment for treatment with or without the confounding factors. Although no association between LH/FSH ratio and biochemical pregnancy, women with 1 ≤ LH/FSH<2 were associated with higher clinical pregnancy (OR = 1.71; 95% CI, 1.09-2.67) and live birth (OR = 1.73; 95% CI, 1.09-2.75) compared to women with LH/FSH<1. Women with 2 ≤ LH/FSH<3 were associated with lower miscarriage rate (OR = 0.38; 95% CI, 0.16-0.93).

CONCLUSIONS

Elevated baseline LH/FSH ratio in women with PCOS was associated with poor ovulatory response, but women were more likely to achieve clinical pregnancy and live birth than women with normal LH/FSH. It suggests LH and FSH in women with PCOS may play a role in successful pregnancy despite of negative impact in ovulation.

摘要

背景

在中国多囊卵巢综合征(PCOS)女性中,排卵诱导后基线促黄体生成素/促卵泡生成素(LH/FSH)比值升高与生殖结局尤其是排卵反应之间存在何种关联。

方法

这是一项对来自中国大陆21个地点(27家医院)的1000例PCOS女性进行的多中心随机试验的二次分析。测量了排卵诱导前的LH和FSH水平以及主要结局,包括排卵、生化妊娠、临床妊娠、流产和活产。使用线性回归模型、逻辑回归模型和Cox比例风险回归模型来估计PCOS中LH/FSH比值与生殖结局之间的关联。

结果

LH/FSH比值与年龄、体重指数(BMI)、总睾酮(TT)、雌二醇(E2)、游离睾酮(FT)和抗苗勒管激素(AMH)显著相关。无排卵女性的LH/FSH比值显著高于有排卵女性(P = 0.003),尤其是在年龄较小(P = 0.023)、BMI较高(P = 0.002)、E2较低(P = 0.002)、FT较低(P = 0.010)、TT较低(P < 0.001)和AMH较低(P = 0.032)的女性中。与LH/FSH<1的女性相比,LH/FSH比值升高的女性排卵率较低(LH/FSH≥1时,OR = 0.42,95%CI,0.26 - 0.68;LH/FSH≥2时,OR = 0.32,95%CI,0.20 - 0.54;LH/FSH≥3时,OR = 0.40,95%CI 0.21 - 0.74)。在调整有无混杂因素的治疗后,这种关联依然存在。虽然LH/FSH比值与生化妊娠之间无关联,但与LH/FSH<1的女性相比,1≤LH/FSH<2的女性临床妊娠率较高(OR = 1.71;95%CI,1.09 - 2.67)和活产率较高(OR = 1.73;95%CI,1.09 - 2.75)。2≤LH/FSH<3的女性流产率较低(OR = 0.38;95%CI,0.16 - 0.93)。

结论

PCOS女性基线LH/FSH比值升高与排卵反应不良相关,但与LH/FSH正常的女性相比,她们更有可能实现临床妊娠和活产。这表明PCOS女性的LH和FSH尽管对排卵有负面影响,但可能在成功妊娠中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/fc44dab419a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/92f162cbc5d9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/cbbc01982b39/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/fc44dab419a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/92f162cbc5d9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/cbbc01982b39/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d32e/9876966/fc44dab419a4/gr3.jpg

相似文献

1
Elevated baseline LH/FSH ratio is associated with poor ovulatory response but better clinical pregnancy and live birth in Chinese women with PCOS after ovulation induction.在接受排卵诱导的中国多囊卵巢综合征女性中,基线促黄体生成素/促卵泡生成素比值升高与排卵反应不良相关,但临床妊娠和活产情况较好。
Heliyon. 2023 Jan 18;9(1):e13024. doi: 10.1016/j.heliyon.2023.e13024. eCollection 2023 Jan.
2
Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.用于多囊卵巢综合征女性促排卵的促性腺激素。
Cochrane Database Syst Rev. 2019 Jan 16;1(1):CD010290. doi: 10.1002/14651858.CD010290.pub3.
3
Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.用于多囊卵巢综合征女性促排卵的促性腺激素。
Cochrane Database Syst Rev. 2015 Sep 9(9):CD010290. doi: 10.1002/14651858.CD010290.pub2.
4
Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.腹腔镜卵巢打孔术用于无排卵性多囊卵巢综合征女性的促排卵治疗
Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD001122. doi: 10.1002/14651858.CD001122.pub5.
5
[Clinical therapeutic effects of acupuncture combined with Chinese herbal medicine on infertility of polycystic ovary syndrome in the patients with ovulation induction with letrozole].针刺联合中药对来曲唑促排卵的多囊卵巢综合征患者不孕症的临床治疗效果
Zhongguo Zhen Jiu. 2018 Jan 12;38(1):27-32. doi: 10.13703/j.0255-2930.2018.01.006.
6
Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome.在使用促性腺激素诱导排卵并随后进行定时性交或宫内人工授精治疗与多囊卵巢综合征相关的不孕症时使用二甲双胍。
Cochrane Database Syst Rev. 2017 Jan 24;1(1):CD009090. doi: 10.1002/14651858.CD009090.pub2.
7
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.用于患有多囊卵巢综合征、月经过少和生育力低下的女性的胰岛素增敏药物(二甲双胍、罗格列酮、吡格列酮、D-手性肌醇)。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6.
8
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.临床诊断为多囊卵巢综合征女性促性腺激素分泌异常的决定因素
J Clin Endocrinol Metab. 1997 Jul;82(7):2248-56. doi: 10.1210/jcem.82.7.4105.
9
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome.二甲双胍用于多囊卵巢综合征女性的促排卵(不包括促性腺激素)。
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD013505. doi: 10.1002/14651858.CD013505.
10
Inositol for subfertile women with polycystic ovary syndrome.多囊卵巢综合征不孕女性使用肌醇的情况。
Cochrane Database Syst Rev. 2018 Dec 20;12(12):CD012378. doi: 10.1002/14651858.CD012378.pub2.

引用本文的文献

1
Insulin resistance as a determinant of fertilization efficiency in polycystic ovary syndrome patients undergoing IVF/ICSI: a retrospective cohort study.胰岛素抵抗作为多囊卵巢综合征患者体外受精/卵胞浆内单精子注射受精效率的决定因素:一项回顾性队列研究
Reprod Biol Endocrinol. 2025 Sep 1;23(1):120. doi: 10.1186/s12958-025-01453-5.
2
The role of neonatal kisspeptin in long-term social behavior in mammals.新生儿亲吻素在哺乳动物长期社会行为中的作用。
Commun Biol. 2025 Jul 22;8(1):1085. doi: 10.1038/s42003-025-08478-x.
3
Effect of GnRH antagonist pretreatment before controlled ovarian stimulation in antagonist protocol for infertile women with PCOS undergoing IVF/ICSI: A propensity score matching analysis.

本文引用的文献

1
Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.探讨抗苗勒管激素和 LH/FSH 比值在多囊卵巢综合征诊断中的作用。
Clin Endocrinol (Oxf). 2019 Apr;90(4):579-585. doi: 10.1111/cen.13934. Epub 2019 Feb 10.
2
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.多囊卵巢综合征不孕妇女在接受辅助生殖时的体外成熟。
Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD006606. doi: 10.1002/14651858.CD006606.pub4.
3
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
GnRH拮抗剂预处理在多囊卵巢综合征不孕女性体外受精/卵胞浆内单精子注射拮抗剂方案控制性卵巢刺激中的作用:一项倾向评分匹配分析
Medicine (Baltimore). 2025 Jun 27;104(26):e42965. doi: 10.1097/MD.0000000000042965.
4
The Effect of AMH on Folliculogenesis.抗缪勒管激素对卵泡发生的影响。
Reprod Sci. 2025 May 23. doi: 10.1007/s43032-025-01879-7.
5
Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome.多囊卵巢综合征患者的高雄激素血症与人体测量学参数。
BMC Endocr Disord. 2024 Sep 27;24(1):201. doi: 10.1186/s12902-024-01733-y.
6
Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial.联合小剂量人绒毛膜促性腺激素(hCG)和枸橼酸氯米酚(CC)与持续 CC 治疗 CC 抵抗型多囊卵巢综合征患者排卵诱导的疗效比较:一项随机对照试验。
Medicina (Kaunas). 2024 Aug 12;60(8):1300. doi: 10.3390/medicina60081300.
7
Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome.靶向抑制 kisspeptin 神经元可逆转多囊卵巢综合征临床前小鼠模型中的高雄激素血症和异常的 LH 分泌过度活跃。
Hum Reprod. 2024 Sep 1;39(9):2089-2103. doi: 10.1093/humrep/deae153.
8
The Role of Oxytocin in Polycystic Ovary Syndrome: A Systematic Review.催产素在多囊卵巢综合征中的作用:一项系统评价
Curr Issues Mol Biol. 2024 May 25;46(6):5223-5241. doi: 10.3390/cimb46060313.
9
Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles.多囊卵巢综合征(PCOS)患者行 GnRH 拮抗剂方案 IVF/ICSI 周期中卵巢反应不良的预测模型的建立与验证。
J Ovarian Res. 2024 May 28;17(1):116. doi: 10.1186/s13048-024-01437-w.
10
Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome.多囊卵巢综合征患者使用来曲唑促排卵反应的预测因素。
BMC Endocr Disord. 2023 Apr 25;23(1):90. doi: 10.1186/s12902-023-01336-z.
多囊卵巢综合征:定义、病因、诊断与治疗。
Nat Rev Endocrinol. 2018 May;14(5):270-284. doi: 10.1038/nrendo.2018.24. Epub 2018 Mar 23.
4
Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.针刺与克罗米芬对中国多囊卵巢综合征女性的影响:一项随机临床试验
JAMA. 2017 Jun 27;317(24):2502-2514. doi: 10.1001/jama.2017.7217.
5
CLINICAL PRACTICE. Polycystic Ovary Syndrome.临床实践。多囊卵巢综合征。
N Engl J Med. 2016 Jul 7;375(1):54-64. doi: 10.1056/NEJMcp1514916.
6
What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.对于多囊卵巢综合征且促黄体生成素/促卵泡生成素比值高的女性,最佳治疗方法是什么?GnRH激动剂、GnRH拮抗剂体外受精与体外成熟之间的比较。
J Endocrinol Invest. 2016 Jul;39(7):799-803. doi: 10.1007/s40618-015-0429-x. Epub 2016 Jan 21.
7
Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome.多囊卵巢综合征患者促黄体生成素/促卵泡生成素比值升高对促排卵的预测价值
J Reprod Med. 2015 Nov-Dec;60(11-12):495-500.
8
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.多囊卵巢综合征的诊断与治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2013 Dec;98(12):4565-92. doi: 10.1210/jc.2013-2350. Epub 2013 Oct 22.
9
Prevalence of polycystic ovary syndrome in women in China: a large community-based study.多囊卵巢综合征在中国女性中的流行情况:一项大型基于社区的研究。
Hum Reprod. 2013 Sep;28(9):2562-9. doi: 10.1093/humrep/det262. Epub 2013 Jun 27.
10
Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment.高促黄体生成素/促卵泡生成素比值对接受体外成熟治疗的多囊卵巢综合征女性的影响。
J Reprod Med. 2013 May-Jun;58(5-6):219-23.